Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microcirculatory and Macrocirculatory Effects of Landiolol on Postoperative Atrial Fibrillation
2018-000307-17Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of landiolol in Atrial fibrillation (AFib) (2 arms), sponsored by Hospices Civils de Lyon. Started Feb 2018; status: completed.
02
Drugs
landiolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2018-000307-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000307-17.